PAHC 23.39 (-1.52%)
US71742Q1067Drug ManufacturersDrug Manufacturers - Specialty & Generic

Phibro Animal Health (PAHC) Competitor Comparison

We are evaluating the key criteria listed to compare Phibro Animal Health (PAHC) against its competitors in the Drug Manufacturers - Specialty & Generic industry.

Linearity 10 years - PAHC ranking 7 / 54

These are the competitors of Phibro Animal Health in the industry Drug Manufacturers - Specialty & Generic ranked by linearity 10 years
1. Theratechnologies THTX
123.17
2. Evolus EOLS
59.58
3. ANI Pharmaceuticals ANIP
30.86
4. Alvotech ALVO
23.3
5. Regencell Bioscience Holdings RGC
14.51
6. ProPhase Labs PRPH
14.25
7. Phibro Animal Health PAHC
9.8
8. Eagle Pharmaceuticals EGRX
9.12
9. Avadel Pharmaceuticals AVDL
8.49
10. Alimera Sciences ALIM
7.61
11. Vifor Pharma G2AB.F
7.23
12. Green Thumb Industries R9U2.F
6.8
13. Emergent BioSolutions EBS
6.41
14. Linc LNC
5.76
15. PetIQ PETQ
5.4
16. Kolinpharma KIP.MI
4.84
17. Ironwood Pharmaceuticals IRWD
4.06
18. Societal CDMO SCTL
3.72
19. Ayr Wellness 3KJB.F
3.68
20. Organogenesis Holdings ORGO
3.67
21. Amneal Pharmaceuticals AMRX
3.6
22. Curaleaf Holdings CURLF
3.22
23. Kamada KMDA
3.2
24. Cumberland Pharmaceuticals CPIX
3.19
25. Elanco Animal Health ELAN
3.11
26. Taro Pharmaceutical Industries TARO
2.87
27. Journey Medical DERM
2.85
28. Tilray Brands TLRY
2.8
29. Cronos Group CRON
2.64
30. Procaps Group PROC
2.57
31. Embecta EMBC
2.51
32. Catalent CTLT
2.47
33. Neoleukin Therapeutics NLTX
2.29
34. Pacira BioSciences PCRX
2.28
35. Teva Pharmaceutical Industries TEVA
2.12
36. Perrigo PRGO
2.09
37. Alpha Teknova TKNO
1.87
38. Jupiter Wellness JUPW
1.84
39. Biofrontera BFRI
1.78
40. Flora Growth FLGC
1.77
41. Ascend Wellness Holdings AAWH
1.76
42. OptiNose OPTN
1.72
43. Zynerba Pharmaceuticals ZYNE
1.63
44. Clever Leaves Holdings CLVR
1.62
45. Relmada Therapeutics RLMD
1.58
46. Universe Pharmaceuticals UPC
1.58
47. Bausch Health Companies BHC
1.56
48. Solid Biosciences SLDB
1.5
49. SCYNEXIS SCYX
1.42
50. Collegium Pharmaceutical COLL
1.24
51. Supernus Pharmaceuticals SUPN
1.14
52. Zoetis ZTS
0.82
53. Harrow Health HROW
0.62
54. Amphastar Pharmaceuticals AMPH
0.46

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.